SCHEMBL16156188

SCHEMBL16156188

COc1cc2ncnc(Nc3cnc4c(c3)CCN4)c2cc1OC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 17/20 0.59
▸ LCK P06239 9/20 0.59
▸ KDR P35968 5/20 0.55
▸ RET P07949 4/20 0.55
▸ SRC P12931 2/20 0.55
▸ GAK O14976 2/20 0.55
▸ CLK1 P49759 1/20 0.55
▸ ABCG2 Q9UNQ0 1/20 0.55
▸ PDGFRB P09619 1/20 0.54
▸ PDGFRA P16234 1/20 0.54
▸ FLT1 P17948 1/20 0.53
▸ RIPK2 O43353 1/20 0.53
▸ STK10 O94804 1/20 0.53
▸ FLT3 P36888 1/20 0.53
▸ JAK3 P52333 1/20 0.53
▸ AAK1 Q2M2I8 1/20 0.53
▸ Q6ZSR9 Q6ZSR9 1/20 0.53
▸ SLK Q9H2G2 1/20 0.53
▸ IRAK4 Q9NWZ3 1/20 0.53
▸ RPS6KA6 Q9UK32 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16150108 0.82 EGFR (0.69) EGFRLCKKDRRETGAK
Hydrochloric Acid SCHEMBL16150696 0.81 EGFR (0.69) EGFRLCKKDRRETGAK
SCHEMBL16150570 0.79 EGFR (0.52) EGFRLCKKDRCLK1ABCG2
SCHEMBL19035526 0.78 EGFR (0.62) EGFRLCKKDRRETSRC
SCHEMBL5652748 0.74 KDR (0.72) EGFRLCKKDRRETSRC
SCHEMBL2659830 0.74 KDR (0.61) EGFRLCKKDRRETGAK
SCHEMBL7705790 0.74 EGFR (1.00) EGFRLCKKDRRETSRC
Hydrochloric Acid SCHEMBL6180756 0.74 EGFR (1.00) EGFRLCKKDRRETGAK
SCHEMBL8976587 0.72 EGFR (0.70) EGFRLCKKDRRETSRC
SCHEMBL5478005 0.72 EGFR (1.00) EGFRLCKKDRRETGAK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9688662-B2 N-(2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-5-yl)-4-quinazolinamine and N-(2,3-dihydro-1H-indol-5-yl)-4-quinazolinamine derivatives as perk inhibitors JANSSEN PHARMACEUTICA NV (BE) 2017-06-27 — — US disclosed
EP-2989091-B1 NOVEL N-(2,3-DIHYDRO-1H-PYRROLO[2,3-B]PYRIDIN-5-YL)-4- QUINAZOLINAMINE AND N-(2,3-DIHYDRO-1H-INDOL-5-YL)-4- QUINAZOLINAMINE DERIVATIVES AS PERK INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2017-05-10 — — EP disclosed
WO-2014161808-A1 NOVEL N-(2,3-DIHYDRO-1H-PYRROLO[2,3-B]JPYRIDIN-5-YL)-4- QUINAZOLINAMINE AND N-(2,3-DIHYDRO-1H-INDOL-5-YL)-4- QUINAZOLINAMINE DERIVATIVES AS PERK INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2014-10-09 — — WO disclosed
Send feedback